<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02258399</url>
  </required_header>
  <id_info>
    <org_study_id>RE-FH1109</org_study_id>
    <nct_id>NCT02258399</nct_id>
  </id_info>
  <brief_title>Exercise in the Fasted State, Glucose Metabolism and Energy Balance</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bath</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Stirling</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bath</source>
  <brief_summary>
    <textblock>
      The ability to control our blood glucose (sugar) concentrations after a meal is a strong
      predictor of the risk of disease. Our bodies respond to glucose ingestion by reducing the
      amount of glucose from the liver entering the bloodstream. At the same time muscle increases
      the amount of glucose it take up from the bloodstream. This ensures that our blood glucose
      levels do not get too high. The investigators want to understand what happens to these
      processes following exercise after breakfast and after an overnight fast. In addition, the
      investigators also want to understand whether exercising with or without breakfast influences
      our appetite, food intake and activity levels later in the day.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exogenous glucose appearance rate</measure>
    <time_frame>120 minutes</time_frame>
    <description>Exogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energy balance</measure>
    <time_frame>24 hours</time_frame>
    <description>Energy balance (intake minus expenditure) over 24 h from the beginning of the trial</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endogenous glucose appearance rates</measure>
    <time_frame>120 minutes</time_frame>
    <description>Endogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose clearance rates</measure>
    <time_frame>120 minutes</time_frame>
    <description>Glucose clearance rates following an oral glucose tolerance test (total clearance over 120 minutes).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy intake</measure>
    <time_frame>24 h</time_frame>
    <description>Weighted energy intake over 24 hours from the beginning of the trial.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>24 h</time_frame>
    <description>Energy expenditure, derived from indirect calorimetry, acccelerometry and heart rate monitoring.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exogenous glucose appearance rates</measure>
    <time_frame>120 minutes</time_frame>
    <description>Exogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Energy Balance</condition>
  <condition>Blood Glucose</condition>
  <arm_group>
    <arm_group_label>Breakfast Rest</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Breakfast Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fasted Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Moderate intensity exercise</description>
    <arm_group_label>Breakfast Exercise</arm_group_label>
    <arm_group_label>Fasted Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Breakfast</intervention_name>
    <description>Breakfast consumption</description>
    <arm_group_label>Breakfast Rest</arm_group_label>
    <arm_group_label>Breakfast Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males.

          -  Aged 18-49.

          -  Individuals free from known cardiovascular, metabolic or joint disease as determined
             by standard health questionnaire.

          -  Habitual regularly participating in exercise (minimum of 3 sessions per week on
             average)

          -  Non-smoker

        Exclusion Criteria:

          -  Known or suspected food intolerances, allergies or hypersensitivity.

          -  Any bleeding disorder or taking medication which impacts blood coagulation.

          -  Known tendency towards keloid scarring.

          -  Known sensitivity or allergy to any local anaesthetic medicines.

          -  Any reported use of substances which may pose undue personal risk to participants or
             introduce bias into the experiment.

          -  Any other condition or behaviour deemed either to pose undue personal risk to
             participants or introduce bias into the experiment.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department for Health, University of Bath</name>
      <address>
        <city>Bath</city>
        <zip>BA2 7AY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Gonzalez JT. Paradoxical second-meal phenomenon in the acute postexercise period. Nutrition. 2014 Sep;30(9):961-7. doi: 10.1016/j.nut.2013.12.001. Epub 2013 Dec 14. Review.</citation>
    <PMID>24986552</PMID>
  </reference>
  <reference>
    <citation>Gonzalez JT, Veasey RC, Rumbold PL, Stevenson EJ. Breakfast and exercise contingently affect postprandial metabolism and energy balance in physically active males. Br J Nutr. 2013 Aug;110(4):721-32. doi: 10.1017/S0007114512005582. Epub 2013 Jan 29.</citation>
    <PMID>23340006</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2014</study_first_submitted>
  <study_first_submitted_qc>October 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2014</study_first_posted>
  <last_update_submitted>March 30, 2018</last_update_submitted>
  <last_update_submitted_qc>March 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bath</investigator_affiliation>
    <investigator_full_name>Javier Gonzalez</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

